Biological Activity In Vitro, Absorption,
BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonistwith Disease-Modifying Potential for the Treatment of Neurodegeneration. Here, RET is linked to neurodegenerative disease.